A mitochondria-targeted peptide studied for cristae stability and cellular energy efficiency.
SS-31 reconstitutes to a set concentration. Add 0.5 mL of bacteriostatic water to a 10 mg vial for a 20 mg/mL solution.
| Vial size | BAC water | Concentration | 2 mg draws to |
|---|---|---|---|
| 10 mg | 0.5 mL | 20 mg/mL | 10 units |
| 50 mg | 2.5 mL | 20 mg/mL | 10 units |
Units are shown for a U-100 insulin syringe. A common starting dose is 2 mg. At 20 mg/mL, that draws to 10 units on a U-100 insulin syringe.
Binds cardiolipin in the inner mitochondrial membrane to stabilize cristae structure. This enhances electron transport chain efficiency and reduces reactive oxygen species.
SS-31 is commonly taken in the morning.
Add 0.5 mL of bacteriostatic water to a 10 mg SS-31 vial for a 20 mg/mL solution.
A common SS-31 starting dose is 2 mg, which at 20 mg/mL draws to 10 units on a U-100 insulin syringe.
Draw bacteriostatic water into a syringe, inject it slowly down the inside glass of the SS-31 vial (not onto the powder), and swirl gently until clear. Store refrigerated and use within the common window.
Add 0.5 mL of bacteriostatic water to a 10 mg SS-31 vial for a 20 mg/mL solution. A 2 mg dose then draws to 10 units on a U-100 insulin syringe.
Add 2.5 mL of bacteriostatic water to a 50 mg SS-31 vial for a 20 mg/mL solution. A 2 mg dose then draws to 10 units on a U-100 insulin syringe.